OTCMKTS:PRVCF PreveCeutical Medical (PRVCF) Stock Price, News & Analysis $0.03 +0.00 (+17.59%) As of 08/1/2025 11:28 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort InterestBuy This Stock About PreveCeutical Medical Stock (OTCMKTS:PRVCF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PreveCeutical Medical alerts:Sign Up Key Stats Today's Range$0.03▼$0.0350-Day Range$0.02▼$0.0352-Week Range$0.01▼$0.03Volume3,000 shsAverage Volume39,600 shsMarket Capitalization$14.49 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada. Read More Receive PRVCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address PRVCF Stock News HeadlinesPRVCF PreveCeutical Medical Inc. - Seeking AlphaJuly 2, 2025 | seekingalpha.comPreveCeutical Appoints Dr. Francis Tavares as CTO to Enhance Drug Discovery EffortsJune 30, 2025 | tipranks.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks. | American Alternative (Ad)PreveCeutical Appoints Dr. Deepak Sampath as Corporate AdvisorJune 2, 2025 | tipranks.comPreveCeutical Appoints Stephen Glover as Corporate Advisor to Boost Strategic GrowthMay 26, 2025 | tipranks.comPreveCeutical Completes Private Placement to Boost R&D EffortsMay 22, 2025 | tipranks.comPreveCeutical’s BioGene Launches New Website to Boost Digital EngagementMay 14, 2025 | tipranks.comPreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc. ...May 14, 2025 | gurufocus.comSee More Headlines PRVCF Stock Analysis - Frequently Asked Questions How have PRVCF shares performed this year? PreveCeutical Medical's stock was trading at $0.0184 at the start of the year. Since then, PRVCF shares have increased by 38.0% and is now trading at $0.0254. How do I buy shares of PreveCeutical Medical? Shares of PRVCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today8/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryN/A Current SymbolOTCMKTS:PRVCF CIKN/A Webwww.preveceutical.com Phone(604) 416-7777Fax778-945-6290EmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$860 thousand Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-603.63% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-2.54Miscellaneous Outstanding Shares570,650,000Free FloatN/AMarket Cap$14.49 million OptionableNot Optionable Beta0.32 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTCMKTS:PRVCF) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PreveCeutical Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PreveCeutical Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.